These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28596421)

  • 1. Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma.
    Hammarstrand C; Ragnarsson O; Hallén T; Andersson E; Skoglund T; Nilsson AG; Johannsson G; Olsson DS
    Eur J Endocrinol; 2017 Sep; 177(3):251-256. PubMed ID: 28596421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma.
    Zueger T; Kirchner P; Herren C; Fischli S; Zwahlen M; Christ E; Stettler C
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1938-42. PubMed ID: 22872686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.
    Olsson DS; Nilsson AG; Bryngelsson IL; Trimpou P; Johannsson G; Andersson E
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2651-8. PubMed ID: 25946030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study.
    Olsson DS; Bryngelsson IL; Ragnarsson O
    Pituitary; 2017 Apr; 20(2):218-224. PubMed ID: 27743172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients.
    Ragnarsson O; Mattsson AF; Monson JP; Filipsson Nyström H; Åkerblad AC; Kołtowska-Häggström M; Johannsson G
    Eur J Endocrinol; 2014 Nov; 171(5):571-9. PubMed ID: 25127712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.
    Olsson DS; Trimpou P; Hallén T; Bryngelsson IL; Andersson E; Skoglund T; Bengtsson BÅ; Johannsson G; Nilsson AG
    Eur J Endocrinol; 2017 Jan; 176(1):67-75. PubMed ID: 27770012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational use of glucocorticoid during pituitary surgery--a pilot study.
    Bhansali A; Dutta P; Bhat MH; Mukherjee KK; Rajput R; Bhadada S
    Indian J Med Res; 2008 Sep; 128(3):294-9. PubMed ID: 19052341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.
    Nilsson B; Gustavasson-Kadaka E; Bengtsson BA; Jonsson B
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1420-5. PubMed ID: 10770176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular events, secondary intracranial tumors, and mortality after radiotherapy for nonfunctioning pituitary adenomas: a subanalysis from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Ubachs DH; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1104-12. PubMed ID: 25574793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres.
    O'Reilly MW; Reulen RC; Gupta S; Thompson CA; Dineen R; Goulden EL; Bugg G; Pearce H; Toogood AA; Gittoes NJ; Mitchell R; Thompson CJ; Ayuk J
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):748-756. PubMed ID: 27327840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypopituitarism and mortality in pituitary adenoma.
    Lindholm J; Nielsen EH; Bjerre P; Christiansen JS; Hagen C; Juul S; Jørgensen J; Kruse A; Laurberg P; Stochholm K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):51-8. PubMed ID: 16817819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
    Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
    Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
    Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study.
    Olsson DS; Bryngelsson IL; Ragnarsson O
    Eur J Endocrinol; 2016 Jul; 175(1):55-61. PubMed ID: 27147638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up.
    Ntali G; Capatina C; Fazal-Sanderson V; Byrne JV; Cudlip S; Grossman AB; Wass JA; Karavitaki N
    Eur J Endocrinol; 2016 Feb; 174(2):137-45. PubMed ID: 26546611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma.
    Olsson DS; Hammarstrand C; Bryngelsson IL; Nilsson AG; Andersson E; Johannsson G; Ragnarsson O
    Endocr Relat Cancer; 2017 May; 24(5):227-235. PubMed ID: 28274953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in patients with non-functioning pituitary adenoma: a special focus on hydrocortisone replacement dose.
    Wild CM; Stieg M; Stalla GK; Auer MK; Athanasoulia-Kaspar AP
    Qual Life Res; 2020 Dec; 29(12):3325-3331. PubMed ID: 32737686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare cost and survival in patients with non-functioning pituitary adenoma.
    Olsson DS; Svensson M; Labori F; De Geer A; Johannsson G
    Eur J Endocrinol; 2023 Jun; 188(6):477-484. PubMed ID: 37232269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk profile in growth hormone-treated adults with craniopharyngioma compared to non-functioning pituitary adenoma: a national cohort study.
    Verweij T; Slagboom TNA; van Varsseveld NC; van der Lely AJ; Drent ML; van Bunderen CC
    Eur J Endocrinol; 2021 Oct; 185(6):793-801. PubMed ID: 34605771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study.
    Esposito D; Ragnarsson O; Granfeldt D; Marlow T; Johannsson G; Olsson DS
    Eur J Endocrinol; 2018 May; 178(5):459-469. PubMed ID: 29483205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.